SINOVAC BIOTECH LTD.
Consolidated Statements of Income and Comprehensive Income
Three Months and Six Months Ended June 30, 2009 and 2008
(Unaudited)
(Expressed in U.S. Dollars)
Three months ended Six months ended
30-Jun 30-Jun
2009 2008 2009 2008
Sales $20,018,327 $16,521,429 $26,584,426 $25,383,430
Cost of sales 3,762,786 2,613,939 5,210,556 3,661,805
Gross profit 16,255,541 13,907,490 21,373,870 21,721,625
Selling, general and
administrative
expenses 4,860,279 6,038,650 8,407,902 9,616,536
Research and
development expenses 549,734 667,508 1,309,175 1,596,844
Depreciation of
property, plant and
equipment and
amortization of
licenses and permits 167,004 169,484 331,873 347,713
Total operating
expenses 5,577,017 6,875,642 1
'/>"/>
| SOURCE Sinovac Biotech Ltd. Copyright©2009 PR Newswire. All rights reserved |